Spots Global Cancer Trial Database for ro7300490
Every month we try and update this database with for ro7300490 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors | NCT04857138 | Solid Tumors | RO7300490 Atezolizumab | 18 Years - | Hoffmann-La Roche | |
A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors | NCT04857138 | Solid Tumors | RO7300490 Atezolizumab | 18 Years - | Hoffmann-La Roche | |
A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors | NCT04857138 | Solid Tumors | RO7300490 Atezolizumab | 18 Years - | Hoffmann-La Roche |